An etiopathological study of palmoplantar psoriasis
Phase 2
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/05/052620
- Lead Sponsor
- ational institute of Ayurveda deemed to be university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patient with the classical sign and symptoms of Vipadika Kustha
2) Patients will be selected irrespective of sex, caste, occupation, socio-economic status.
3) Patients in detail.
willing to participate in the study will be selected by explaining the interventions
4)Patient willing to give written informed consent.
5) Patient willing to follow up.
Exclusion Criteria
1. The patient suffering from malignant systemic disorders, especially those are mentioned as Asadhya Vyadhi as per clinical text of Ayurveda will be excluded.
2. Patient with history of psoriasis.
3. Patient on some other medication.
4. Patient with other systemic disorders like DM etc.
5. Patient under other treatments of Vipadika
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) To compare the efficacy of Sarjarasa Lepa and Dhaturbeej Taila in the Management of Vipadika in terms of change in Ayurvedic Symptom Score before and after intervention Le. between day 0 and Day 30Timepoint: 2 month
- Secondary Outcome Measures
Name Time Method 1) To study the etiopathogenesis of Vipadika Kustha <br/ ><br>2) To evaluate the efficacy of Dhaturbeej taila in the management of Vipadika. <br/ ><br>3) To evaluate the efficacy of Sarjarasa Lepa in the management of Vipadika. <br/ ><br>4) To assess the change in Dermatology Life Quality Index (DLQI) (Appendix 1) before <br/ ><br>and after intervention i.e. b/w day 0 and day 30Timepoint: 2 month